logo
Muscle loss to cancer: Shubhanshu Shukla's mission targets health in space

Muscle loss to cancer: Shubhanshu Shukla's mission targets health in space

As part of Axiom Mission 4 (Ax-4), Indian astronaut Group Captain Shubhanshu Shukla is leading a suite of life science experiments that could reshape healthcare, both in orbit and on Earth.
The Ax-4 crew is conducting around 60 scientific and commercial studies in microgravity. India, through Indian Space Research Organisation (Isro), has contributed seven key experiments to this mission, spanning muscle loss, cancer biology, diabetes care, and brain activity.
Battling muscle loss in space
Among Shukla's flagship projects is the Myogenesis experiment, conducted in the ISS's Life Sciences Glovebox. In microgravity, bones weaken and muscle atrophy sets in rapidly, particularly in postural muscles.
According to Nasa, astronauts may lose up to 1 per cent of bone density per month in space. The European Space Agency (ESA) reports that muscle loss of 10–20 per cent has been recorded on short missions—rising to 50 per cent during longer ones. Even astronauts like Sunita Williams, despite rigorous training, have faced this challenge.
'What happens on going to space is that because gravity is absent, the load goes away and hence muscle loss occurs. So, my experiment is looking at whether we can stop or delay this muscle loss by giving some supplement,' Shukla told Prime Minister Narendra Modi in a live interaction from orbit.
'It has a direct implication on Earth too—these supplements can be used on people who suffer muscle loss due to old age. So, I think it can definitely be used there,' he added.
The project is led by the Institute of Stem Cell Science and Regenerative Medicine (InStem). 'Our research could one day help astronauts stay fit in space—and assist the elderly or immobile patients back on Earth,' said Dr Shruti Naik of InStem.
Testing diabetes management in space
Another cutting-edge experiment is the Suite Ride study, which monitors glucose metabolism and insulin effectiveness in space. One astronaut is wearing a continuous glucose monitor (CGM) throughout the mission, allowing scientists to compare blood sugar trends in real time.
Blood samples collected aboard the ISS will be analysed to check the accuracy of CGM data. Two types of insulin pens—one stored cold, another at room temperature—are also being tested to determine efficacy in space environments.
The findings could benefit both diabetic astronauts and patients on Earth, particularly those in remote areas or intensive care settings.
Probing brain activity and cognitive response
The PhotonGrav experiment explores brain activity using wearable EEG sensors. It examines cerebral blood flow and brain-computer interfacing in microgravity—research that could one day support thought-controlled spacecraft and enhance neuro-rehabilitation therapies for stroke patients.
Studying cancer cell behaviour in orbit
The Cancer in LEO (Low Earth Orbit) project, run by the Sanford Stem Cell Institute, involves studying triple-negative breast cancer organoids in space. The goal is to identify early warning signs and test new drug targets in microgravity.
This work contributes to a broader initiative examining how microgravity affects stem cells, aging, and disease—laying the foundation for next-gen cancer treatments and diagnostic tools.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

In a call to ISRO chief, Shukla acknowledges his efforts in ensuring his safe travel to ISS
In a call to ISRO chief, Shukla acknowledges his efforts in ensuring his safe travel to ISS

Indian Express

time12 minutes ago

  • Indian Express

In a call to ISRO chief, Shukla acknowledges his efforts in ensuring his safe travel to ISS

In a call to V Narayanan, Chairman of Indian Space Research Organisation (ISRO), Shubhanshu Shukla, the Indian Gaganyatri currently aboard the International Space Station (ISS) as part of the Axiom-4 mission, acknowledged the efforts of team ISRO in ensuring his safe travel to the ISS. Shukla had called the ISRO chief on July 6 afternoon, ISRO said. During the call, the chairman expressed his keen interest in Shukla's well-being and inquired about the various scientific experiments and activities being conducted on the ISS. Narayanan, also Secretary of Department of Space, emphasised the significance of documenting all experiments and activities meticulously after Shukla's return to Earth, as this will provide valuable insights and inputs for the development of India's human spaceflight programme, Gaganyaan. According to ISRO, the Gaganyaan programme aims to demonstrate India's capability to launch a crewed spacecraft into low Earth orbit, and the experiences and knowledge gained from this mission will be crucial for its success. Shubhanshu Shukla's ISS mission has been executed under the ISRO-Axiom Spaceflight agreement. The discussion was attended by several senior officials from ISRO, including Dr Unnikrishnan Nair, Director of Vikram Sarabhai Space Centre (VSSC) and Chairman of the Program Management Council for Human Space Programme; M Mohan, Director of Liquid Propulsion Systems Centre (LPSC); Padmakumar E S, Director of ISRO Inertial Systems Unit (IISU); M Ganesh Pillai, Scientific Secretary of ISRO; and N Vedachalam, former Director of LPSC. Shukla also shared updates on the progress of the experiments and activities being carried out on the space station, highlighting the scientific objectives and the challenges being addressed. PTI

Eli Lilly and Novo Nordisk compete in India's growing weight-loss drug market
Eli Lilly and Novo Nordisk compete in India's growing weight-loss drug market

First Post

time27 minutes ago

  • First Post

Eli Lilly and Novo Nordisk compete in India's growing weight-loss drug market

The incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst three globally for high obesity rates, according to a study published in the medical journal The Lancet read more Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market share, data from research firm Pharmarack showed on Monday. Lilly's Mounjaro, launched in late March, doubled its sales in June to 87,986 units or 260 million rupees ($3.03 million) compared to May, Pharmarack said. Between March and May, Lilly had sold 81,570 Mounjaro units in India. Meanwhile, Novo sold 1,788 units of Wegovy in India since its late-June launch with 25.3 million rupees in sales, Pharmarack said. STORY CONTINUES BELOW THIS AD The incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst three globally for high obesity rates, according to a study published in the medical journal The Lancet. The Indian obesity drug market has grown fivefold since 2021 and is valued at 6.28 billion rupees, according to the research firm. Affordability and willingness to try new drugs for obesity have propelled the growth of the market, Pharmarack's Vice President (Commercial) Sheetal Sapale said. Wegovy's active ingredient, semaglutide, dominates the market with a two-thirds share in India, while Mounjaro's active ingredient, tirzepatide, has captured 8% of the market, Pharmarack said. As of June, the semaglutide market in India was valued at 4.12 billion rupees, and tirzepatide at 500 million rupees, the research firm said. Novo has sold oral versions of semaglutide for diabetes in India since 2022. Semaglutide will lose patent protection in India in 2026, and generic drugmakers are aiming to produce cheaper versions of Wegovy as India becomes a key battleground for drugmakers seeking to grab a share of the global obesity market. Novo and Lilly's drugs help control blood sugar and slow digestion, making users feel fuller for longer. STORY CONTINUES BELOW THIS AD ($1 = 85.9200 Indian rupees)

NASA astronaut captures rare red sprite from International Space Station: What the Striking image reveals
NASA astronaut captures rare red sprite from International Space Station: What the Striking image reveals

Time of India

time29 minutes ago

  • Time of India

NASA astronaut captures rare red sprite from International Space Station: What the Striking image reveals

A breathtaking photograph taken from the International Space Station (ISS) by NASA astronaut Nichole Ayers has captured one of Earth's most elusive atmospheric phenomena: the red sprite . Snapped as the space station passed over Mexico and the United States on July 3, 2025, the image shows a vivid red column shooting upward from a bluish halo in the night sky. Shared on X (formerly Twitter), the photo quickly went viral, amassing over 2.7 million views. While visually stunning, the sprite is also of great scientific interest, offering insight into rarely observed electrical events in Earth's upper atmosphere. What is a Red Sprite captured by NASA astronauts Red sprites are a type of Transient Luminous Event (TLE), which are upper-atmospheric electrical discharges that differ significantly from ordinary lightning. Occurring 30 to 60 miles above Earth's surface, red sprites appear as red or pink flashes caused by energetic electrons colliding with nitrogen molecules. Unlike traditional lightning, which travels downward, sprites shoot upward into the mesosphere and can resemble jellyfish or columns. These phenomena were first photographed in the late 1980s, although pilots reported seeing them as early as the 1950s. Since then, sprites have become a subject of intense scientific interest, especially in how they affect atmospheric chemistry and electromagnetic environments. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like An engineer reveals: One simple trick to get internet without a subscription Techno Mag Learn More Undo The importance of this spectacular phenomenon Nichole Ayers' photo is more than just visually striking; it's scientifically valuable. Observing sprites from space provides a rare opportunity to study electrical activity in parts of the atmosphere that are difficult to monitor from the ground. The clear vantage point from the ISS avoids the interference of clouds and light pollution, offering scientists unparalleled clarity. NASA has highlighted the importance of such images in improving our understanding of storm behavior, atmospheric electricity, and even how these high-altitude flashes might affect aviation and communication systems. The astronaut behind the lens Nichole Ayers, a U.S. Air Force lieutenant colonel and combat-tested fighter pilot, is currently part of Expedition 73 aboard the ISS. A member of NASA's Artemis generation of astronauts, Ayers is engaged in a wide range of scientific missions, from Earth observation to medical experiments. Her ability to capture such a rare event underscores the role astronauts play not just in exploration but in advancing scientific knowledge of our own planet. As Earth-based detection remains limited by weather and geography, space-based monitoring of transient luminous events like sprites will continue to be a vital tool for researchers. With continued technological advancement and astronaut-led observation, phenomena like red sprites may soon become better understood, unlocking new knowledge about Earth's dynamic and mysterious upper atmosphere.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store